Amy C Seila White - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Amy C Seila White

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Bioorganic & Medicinal Chemistry Letters|June 17, 2018

3'-Modification stabilizes mRNA and increases translation in cellsChristian Gampe, Amy C Seila White, Swetha Siva, et al.

RNA (New York, N.Y.)|February 2, 2012

Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivoDonald J Foster, Scott Barros, Rick Duncan, et al.

Cancer Discovery|January 30, 2013

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvementJosep Tabernero, Geoffrey I Shapiro, Patricia M LoRusso, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Bioorganic & Medicinal Chemistry Letters|June 17, 2018

3'-Modification stabilizes mRNA and increases translation in cellsChristian Gampe, Amy C Seila White, Swetha Siva, et al.

RNA (New York, N.Y.)|February 2, 2012

Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivoDonald J Foster, Scott Barros, Rick Duncan, et al.

Cancer Discovery|January 30, 2013

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvementJosep Tabernero, Geoffrey I Shapiro, Patricia M LoRusso, et al.

Pageof 1